Apr 19, 2018 13:00 pm UTC| Business
CAMBRIDGE, Mass., April 19, 2018 -- Diffeo announced today the general availability of new capabilities for Microsoft Exchange email servers and Windows Shared Drives. Several large enterprises are already putting these...
Navios Maritime Acquisition Corporation Announces Sale and Leaseback Transaction
Apr 19, 2018 12:49 pm UTC| Business
MONACO, April 19, 2018 -- Navios Maritime Acquisition Corporation (“Navios Acquisition”) (NYSE:NNA), an owner and operator of tanker vessels, announced today that it has completed a $71.5 million sale and leaseback...
Velocity Achieves Amazon Web Services Oracle Competency Status
Apr 19, 2018 12:46 pm UTC| Business
CHARLOTTE, N.C., April 19, 2018 -- Velocity Technology Solutions Inc., the global leader in enterprise cloud application management services and creator of the Velocity Cloud Application Management PlatformTM (VCAMP®),...
Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited
Apr 19, 2018 12:46 pm UTC| Business
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT...
Free School Gardening Curriculum Offered by Rodale Institute
Apr 19, 2018 12:45 pm UTC| Business
Kutztown, Pennsylvania, April 19, 2018 -- Want to grow engaged, curious learners and teach healthy eating habits? Start in the garden. Studies show that kids who participate in school gardening programs are not only...
Boston Semi Equipment Recognized for Excellence by Texas Instruments
Apr 19, 2018 12:45 pm UTC| Business
BILLERICA, Mass., April 19, 2018 -- Boston Semi Equipment (BSE), a semiconductor test handler manufacturer and provider of test automation technical services, today announced it is a recipient of the 2017 Texas...
Paratek Pharmaceuticals, Inc. Prices $140 Million of Convertible Senior Subordinated Notes due 2024
Apr 19, 2018 12:45 pm UTC| Business
BOSTON, April 19, 2018 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today...